%0 Journal Article
%A Mingot-Castellano, María E
%A Alcalde-Mellado, Patricia
%A Pascual-Izquierdo, Cristina
%A Perez Rus, Gloria
%A Calo Pérez, Aida
%A Martinez, María P
%A López-Jaime, Francisco J
%A Abalo Perez, Lorena
%A Gonzalez-Porras, José R
%A López Fernández, Fernanda
%A Caparrós Miranda, Isabel S
%A González-López, Tomás J
%A Moreno Beltrán, María E
%A Rubio Escuin, Rebeca
%A Jimenez Bárcenas, Reyes
%A on behalf GEPTI (Grupo Español de Trombocitopenia Inmune)
%T Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain.
%D 2021
%U http://hdl.handle.net/10668/17793
%X Infections are one of the well-known precipitating factors for relapses in patients with immune thrombocytopenia (ITP). Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can sometimes lead to or be associated with thrombocytopenia due to an increase in peripheral platelet destruction from inflammatory hyperactivation. Currently, we do not know if SARS-CoV-2 infection modifies the natural evolution of chronic or persistent ITP or if previous immunosuppression of patients with ITP influences the incidence and severity of coronavirus disease 2019 (COVID-19) in this group. The present study was an observational, multicentre, national series of 32 adult patients with pre-existing ITP and subsequent SARS-CoV-2 infection, collected by the Spanish ITP Group [Grupo Español de Trombocitopenia Inmune (GEPTI)].
%K COVID-19
%K ITP
%K chronic
%K persistent
%K steroids
%K treatment
%~